Douglas E. Feldman, Ph.D. - Publications

Affiliations: 
2004 Stanford University, Palo Alto, CA 
Area:
Biology and of Genetics

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Shukla V, Halabelian L, Balagere S, Samaniego-Castruita D, Feldman DE, Arrowsmith CH, Rao A, Aravind L. HMCES Functions in the Alternative End-Joining Pathway of the DNA DSB Repair during Class Switch Recombination in B Cells. Molecular Cell. PMID 31806351 DOI: 10.1016/J.Molcel.2019.10.031  0.34
2015 Uthaya Kumar DB, Chen CL, Liu JC, Feldman DE, Sher LS, French S, DiNorcia J, French SW, Naini BV, Junrungsee S, Agopian VG, Zarrinpar A, Machida K. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-initiating Stem-like Cells in Livers of Mice. Gastroenterology. PMID 26582088 DOI: 10.1053/J.Gastro.2015.11.002  0.358
2015 Siddique HR, Feldman DE, Chen CL, Punj V, Tokumitsu H, Machida K. NUMB Phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by NANOG-dependent mechanism in liver cancer. Hepatology (Baltimore, Md.). PMID 26174965 DOI: 10.1002/Hep.27987  0.374
2015 Machida K, Feldman DE, Tsukamoto H. TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis. Advances in Experimental Medicine and Biology. 815: 131-44. PMID 25427905 DOI: 10.1007/978-3-319-09614-8_8  0.407
2013 Chen CL, Tsukamoto H, Liu JC, Kashiwabara C, Feldman D, Sher L, Dooley S, French SW, Mishra L, Petrovic L, Jeong JH, Machida K. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. The Journal of Clinical Investigation. 123: 2832-49. PMID 23921128 DOI: 10.1172/Jci65859  0.365
2013 Feldman DE, Chen C, Punj V, Machida K. The TBC1D15 oncoprotein controls stem cell self-renewal through destabilization of the Numb-p53 complex. Plos One. 8: e57312. PMID 23468968 DOI: 10.1371/Journal.Pone.0057312  0.389
2012 Machida K, Chen CL, Liu JC, Kashiwabara C, Feldman D, French SW, Sher L, Hyeongnam JJ, Tsukamoto H. Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus. Journal of Gastroenterology and Hepatology. 27: 19-22. PMID 22320911 DOI: 10.1111/J.1440-1746.2011.07010.X  0.348
2012 Feldman DE, Chen C, Punj V, Tsukamoto H, Machida K. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 829-34. PMID 22207628 DOI: 10.1073/Pnas.1114438109  0.356
2011 Machida K, Chen C, Kashiwabara C, Liu J, Feldman D, Hyeongnam JJ, Tsukamoto H. Abstract 2447: Novel TLR4-Nanog stemness pathway in liver cancer stem cells confers resistance to TGF-β-mediated tumor suppression through YAP1 and IGF2BP3-AKT-mTOR Cancer Research. 71: 2447-2447. DOI: 10.1158/1538-7445.Am2011-2447  0.36
2010 Machida K, Liu J, Kashiwabara C, Feldman D, Hyeongnam JJ, Mishra L, Tsukamoto H. Abstract 5357: TLR4-dependent Nanog+ cancer stem cells exhibit defective TGF-β signaling through IGF-Akt-Yap1 pathway Cancer Research. 70: 5357-5357. DOI: 10.1158/1538-7445.Am10-5357  0.37
2007 Koumenis C, Bi M, Ye J, Feldman D, Koong AC. Hypoxia and the Unfolded Protein Response Methods in Enzymology. 435: 275-293. PMID 17998059 DOI: 10.1016/S0076-6879(07)35014-3  0.362
2005 Chen Y, Feldman DE, Deng C, Brown JA, De Giacomo AF, Gaw AF, Shi G, Le QT, Brown JM, Koong AC. Identification of mitogen-activated protein kinase signaling pathways that confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae. Molecular Cancer Research : McR. 3: 669-77. PMID 16380504 DOI: 10.1158/1541-7786.Mcr-05-0181  0.328
2005 Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Molecular Cancer Research : McR. 3: 597-605. PMID 16317085 DOI: 10.1158/1541-7786.Mcr-05-0221  0.395
2003 Feldman DE, Spiess C, Howard DE, Frydman J. Tumorigenic mutations in VHL disrupt folding in vivo by interfering with chaperonin binding. Molecular Cell. 12: 1213-24. PMID 14636579 DOI: 10.1016/S1097-2765(03)00423-4  0.553
2000 Feldman DE, Frydman J. Protein folding in vivo: the importance of molecular chaperones. Current Opinion in Structural Biology. 10: 26-33. PMID 10679467 DOI: 10.1016/S0959-440X(99)00044-5  0.509
1999 Feldman DE, Thulasiraman V, Ferreyra RG, Frydman J. Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC. Molecular Cell. 4: 1051-61. PMID 10635329 DOI: 10.1016/S1097-2765(00)80233-6  0.55
Show low-probability matches.